Renaissance Technologies’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-763,212
| Closed | -$3.75M | – | 4373 |
|
2021
Q3 | $3.75M | Sell |
763,212
-19,600
| -3% | -$96.2K | ﹤0.01% | 1640 |
|
2021
Q2 | $4.13M | Sell |
782,812
-29,800
| -4% | -$157K | 0.01% | 1748 |
|
2021
Q1 | $3.9M | Sell |
812,612
-85,972
| -10% | -$413K | ﹤0.01% | 1806 |
|
2020
Q4 | $3.89M | Buy |
898,584
+74,580
| +9% | +$323K | ﹤0.01% | 1742 |
|
2020
Q3 | $3.4M | Sell |
824,004
-38,250
| -4% | -$158K | ﹤0.01% | 1802 |
|
2020
Q2 | $2.21M | Buy |
862,254
+463,874
| +116% | +$1.19M | ﹤0.01% | 2137 |
|
2020
Q1 | $1.15M | Buy |
398,380
+105,600
| +36% | +$305K | ﹤0.01% | 2359 |
|
2019
Q4 | $1.11M | Buy |
292,780
+169,145
| +137% | +$641K | ﹤0.01% | 2579 |
|
2019
Q3 | $632K | Buy |
+123,635
| New | +$632K | ﹤0.01% | 2782 |
|
2019
Q1 | – | Sell |
-329,081
| Closed | -$2.81M | – | 3791 |
|
2018
Q4 | $2.81M | Buy |
+329,081
| New | +$2.81M | ﹤0.01% | 2057 |
|
2016
Q1 | – | Sell |
-169,900
| Closed | -$4.81M | – | 3593 |
|
2015
Q4 | $4.81M | Sell |
169,900
-141,100
| -45% | -$4M | 0.01% | 1517 |
|
2015
Q3 | $5.21M | Buy |
311,000
+72,367
| +30% | +$1.21M | 0.01% | 1370 |
|
2015
Q2 | $6.26M | Buy |
238,633
+195,833
| +458% | +$5.13M | 0.01% | 1297 |
|
2015
Q1 | $749K | Buy |
+42,800
| New | +$749K | ﹤0.01% | 2446 |
|